Clinical Trials in Gijon, Asturias

Find clinical trials in Gijon, Asturias. Discover local research opportunities and treatment options in your area.

5 Active Trials Found in Gijon

Showing 5 trials on this page

Page 1 of 1

A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma

NCT ID: NCT05730036

This clinical trial is studying a new drug called linvoseltamab to see how well it works for adults with relapsed or refractory multiple myeloma—a type of blood cancer that has come back after trea...

Recruiting

Phase: PHASE3 Conditions: Relapsed Refractory Multiple Myeloma (RRMM)

A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)

NCT ID: NCT06292780

This clinical trial is studying a new treatment called linvoseltamab for adults with a condition known as relapsed or refractory systemic light chain amyloidosis (AL amyloidosis). This is a serious...

Recruiting

Phase: PHASE1 Conditions: Relapsed/Refractory Systemic Light Chain Amyloidosis

A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma

NCT ID: NCT06140524

This clinical trial is exploring a new medication called linvoseltamab to see if it can help eliminate abnormal plasma cells that could lead to conditions like Multiple Myeloma in adults who have e...

Recruiting

Phase: PHASE2 Conditions: Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma (SMM)

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

NCT ID: NCT05156281

This clinical trial is studying the effectiveness and safety of a new treatment called remibrutinib compared to an existing drug, teriflunomide, in people with relapsing multiple sclerosis (RMS). R...

Recruiting

Phase: PHASE3 Conditions: Relapsing Multiple Sclerosis

A Proof-of-Concept Trial to Study the Safety and Activity of Linvoseltamab in Participants With Smoldering Multiple Myeloma at High Risk of Developing Multiple Myeloma

NCT ID: NCT05955508

This clinical trial is testing a new drug called linvoseltamab for people with high-risk smoldering multiple myeloma (SMM), which is a condition where a person has abnormal plasma cells in their bl...

Recruiting

Phase: PHASE2 Conditions: Smoldering Multiple Myeloma (SMM)

Search All Trials Browse All Locations